Cronos Group Inc

CRON•United States

Healthcare United States Drug Manufacturers - Specialty & GenericOptions Available

Need professional-grade analysis? Visit stockanalysis.com

$2.58

+7.95%

End of day

Market Cap

$961.55M

P/E Ratio

N/A

Employees

610

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	—	-1.73	-0.59	1.00	-0.67	-0.35
Calmar	—	—	-3.07	-0.67	1.01	-0.29	-0.49
Sharpe	—	—	-1.36	-0.37	0.58	-0.44	-0.29
Omega	—	—	0.73	0.96	1.15	0.96	0.98
Martin	—	—	-7.59	-1.07	2.15	-0.35	-1.06
Ulcer	—	—	5.67	16.95	12.61	69.86	29.24

Also Listed On

CRON.TO

Toronto Stock Exchange · CAD

$1.30B

Cronos Group Inc (CRON) Price Performance

Cronos Group Inc (CRON) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at $2.58, up 7.95% from the previous close.

Over the past year, CRON has traded between a low of $1.62 and a high of $3.27. The stock has gained 43.3% over this period. It is currently 21.1% below its 52-week high.

Cronos Group Inc has a market capitalization of $961.55M.

About Cronos Group Inc

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

Company Info

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): $87.24M
EBITDA: $-3,353,000
Profit Margin: -6.45%
EPS (TTM): -0.19
Book Value: 2.87

Technical Indicators

52 Week High: $3.43
52 Week Low: $1.60
50 Day MA: $2.63
200 Day MA: $2.45
Beta: 1.24

Valuation

Trailing P/E: N/A
Forward P/E: 29.41
Price/Sales: 6.56
Price/Book: 0.87
Enterprise Value: $336.40M